Juan Vera - 10 May 2023 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
President and CEO, Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Issuer symbol
MRKR
Transactions as of
10 May 2023
Net transactions value
$0
Form type
4
Filing time
11 May 2023, 18:10:29 UTC
Previous filing
01 Mar 2023
Next filing
12 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Employee Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 10 May 2023 Common Stock 100,000 $1.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal annual installments on May 10, 2024, May 10, 2025, May 10, 2026 and May 10, 2027 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.